Page 2 - Cancer Treatment

12 common cancer myths busted: What doctors say you must stop believing

Fact-check Friday: Doctors debunk persistent cancer myths-from sugar and deodorants to breast surgery and mobile phones-that often mislead patients, delay diagnosis, and derail treatment decisions

US doctors remove spinal tumour through eye socket in world-first surgery

In a medical first, US surgeons removed a spinal tumour through a patient's eye socket, a procedure that is being seen as a new hope for treating complex, hard-to-reach tumours with less risk

This cancer therapy stunned researchers. Here's what the trial revealed

Phase-I trial of HSPCAR30 therapy shows 100% response and 50% remission in CD30+ lymphoma patients with no major side effects, boosting hope for targeted, affordable cancer treatment

Cancer treatment top priority for govt, Rs 3K cr allocated, says Nadda

Union Health Minister JP Nadda on Sunday said cancer treatment is a top priority area for policy makers and a sum of Rs 3000 crore has been allocated for the purpose. He was speaking after inaugurating the Truebeam facility (linear accelerator used in radiation oncology) at the State Cancer Institute here. "We have made cancer treatment top priority. We have increased our baseline for screening and detection. In 1,75,000 Ayushman Arogya Mandirs (AAMs), screening for oral, breast and cervical cancer has been conducted. We have made the age of 30 mandatory for screening. Cancer treatment is a priority area for policy makers and we have allocated Rs 3000 crore for the purpose," he said. Nadda said more than 26 crore people have been screened for oral cancer, following which 1.63 lakh cases were detected. "As many as 14.6 crore people were screened for breast cancer, resulting in 57,179 detections. More than 9 crore people were screened for cervical cancer, and 96,973 persons were ...

Hope after chemo: Lymph node removal may boost ovarian cancer survival

A recent study by Aiims, Delhi suggests that removing lymph nodes after chemotherapy may significantly improve survival rates among ovarian cancer patients

Cipla gets USFDA nod to market generic version of cancer drug Abraxane

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) submitted for paclitaxel protein-bound particles for injectable suspension (albumin-bound), 100 mg/vial, single-dose vial, Cipla said in a regulatory filing. Cipla's protein-bound paclitaxel is a generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for injectable suspension 100 mg/vial. Protein-bound paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas. The product is expected to be launched in the first half of the current fiscal year in the US, the Mumbai-based drugmaker said. Shares of the company were trading 2.73 per cent up at Rs 1,454.90 apiece on the BSE.

Biocon Biologics gets US FDA nod for Jobevne, expands oncology portfolio

Jobevne works by blocking a protein called VEGF, which helps tumours grow new blood vessels

World Health Day: Conduct a thorough checkup of your health insurance

Ensure the policy offers adequate sum insured to deal with even critical illnesses, and move out of policies with sub-limits

China unveils booster to amplify immune responses against cancer, viruses

This technology is capable of amplifying immune responses against tumours and infections up to 150-fold

Cancer, neonatal care, and genetic disorders dominate crowdfunding in India

CarePal, the parent company of Impact Guru, in its State of Cancer Fundraising Report 2024, revealed that the top 100 cancer campaigns on Impact Guru in FY24 raised an average of Rs 10 lakh each

King Charles III seen in public a day after hospitalisation for treatment

King Charles III was briefly hospitalised for observation on Thursday after experiencing "temporary side effects" related to a scheduled cancer treatment, Buckingham Palace said in a statement. His engagements for Thursday afternoon and Friday were cancelled. "His majesty has now returned to Clarence House and as a precautionary measure, acting on medical advice, tomorrow's diary programme will also be rescheduled," the palace said. "His majesty would like to send his apologies to all those who may be inconvenienced or disappointed as a result," it added. The king's health has been closely watched ever since early last year when he announced that he had been diagnosed with an undisclosed form of cancer. Charles, 76, stepped away from public duties for about three months but continued fulfilling state duties, such as reviewing government papers and meeting with the prime minister. Charles' cancer diagnosis has heaped pressure on the British monarchy, which is still evolving after

Apollo Hospitals partners with Ion Beam Applications for proton therapy

Apollo Hospitals on Tuesday said it has tied up with Ion Beam Applications to introduce proton beam therapy solutions for cancer treatment. The healthcare major has tied up with Ion Beam Applications to introduce the Proteus One system in India. "The addition of Proteus One to our Apollo Proton Cancer Centres further solidifies our position as a global leader in Proton Therapy. This next-generation technology will allow us to achieve superior clinical outcomes and significantly improve the quality of life for cancer patients in India and beyond," Apollo Hospitals Enterprise Founder-Chairman Prathap C Reddy said in a statement. As per the study published in The Lancet Regional Health, worldwide in terms of absolute incidence number, following China and the US, India ranks third, contributing 7.5 per cent of all new cancer incidences and is expected to grow to 1.5 million this year. Ion Beam Applications CEO Olivier Legrain said: "These contracts expand upon the close relationship we

Timely cancer care improves with Ayushman Bharat in India: Lancet stud

While The Lancet study praised the health safety net created by the government, it also highlighted a critical gap in cancer care infrastructure in India

Budget 2025: Health care gets 9.78% boost, cancer treatment costs to drop

Customs Duty exemption for lifesaving drugs, more money for Ayushman Bharat

Tobacco causes 40% of preventable cancer cases in India, say experts

Cancer continues to claim millions of lives in India, but tobacco consumption which is responsible for about 40 percent of cancer cases in the country is the single largest preventable cause of the disease, doctors said here on Saturday. Besides avoiding tobacco and alcohol, cancer risk can be cut down through lifestyle changes, balanced diet and regular health check-ups, experts said at a seminar organised as part of the 'Jagega Bharat Toh Bachega Bharat' campaign by the Ambagopal Foundation here. "One in five men and one in eight women in India are at risk of developing cancer, due to changing lifestyles, environmental degradation, and lack of awareness. While cancer continues to claim millions of lives, it is largely preventable if individuals adopt healthier lifestyles, avoid tobacco and alcohol consumption, maintain a balanced diet, and undergo regular health check-ups," oncologist Dr Anil D'Cruz said. Tobacco consumption remains "the single largest preventable cause of cancer"

36 life-saving medicines fully exempted from customs duty: FM Sitharaman

Budget 2025: This decision is part of a broader push to make essential healthcare more affordable, especially for cancer patients struggling with the high costs of treatment

Cell & gene therapy statrtup Immuneel unveils CAR-T cancer therapy in India

Immuneel Therapeutics, backed by entrepreneur Kiran Mazumdar-Shaw, offers therapy for CAR T-cell therapy for adult B-cell non-hodgkin lymphoma (B-NHL)

Kate Middleton reveals she is in remission after cancer treatment

Kate Middleton, Britain's Princess of Wales, on Tuesday paid a visit to the Royal Marsden Hospital in London to thank National Health Service (NHS) staff who cared for her during her cancer treatment over the past year and went on to reveal that she was in remission. Her visit marked the first confirmation of where the 43-year-old senior royal underwent her preventative chemotherapy. "It is a relief to now be in remission, and I remain focused on recovery. As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal, said Catherine, Princess of Wales. "I am however looking forward to a fulfilling year ahead. There is much to look forward to. Thank you to everyone for your continued support," she said in a message on social media signed 'C'. Kate reflected that she wanted to visit the London hospital that had looked after her so well during the past year. The Princess of Wales added: "My heartfelt thanks goes to all those who have quietly walk

Health cover against cancer: Check policy for exclusions, sub-limits

Cancer-specific policies, which only cover cancer, are available as indemnity-based or fixed-benefit plans

AstraZeneca and Merck drugs set to shake up treatment of liver cancer

Two late-stage studies published Wednesday in The Lancet show that Astra's Imfinzi and Merck's Keytruda delayed the progress of liver cancer when combined with other drugs and a local treatment